5
Views
7
CrossRef citations to date
0
Altmetric
Research Article

The Hypercoagulability States

, &
Pages 397-429 | Published online: 27 Sep 2008

References

  • Virchow R. Thrombose und embolie. Gesammelte Abhandlungen zur Wissenschaftlichen Median von Rudolf Virchow. von Meidinger, Frankfurt 1856; 219
  • Wessler S. The role of hypercoagulability in venous and arterial thrombosis. Cardiovasc. Clin. 1971; 3(1)1
  • Davie E. W., Fujikawa K. Basic mechanisms in blood coagulation. Annu. Rev. Biochem. 1975; 44: 799
  • Blombäck B., Hogg D. H., Gardlund B., Hessel B., Kudryk B. Fibrinogen and fibrin formation. Thromb. Res. 1976; 8(2)329
  • Owen C. A., Bowie E. J. W., Thompson J. H. The Diagnosis of Bleeding Disorders2nd ed. Little, Brown, Boston 1975
  • Gröttum K. A., Hjort P. F., Jeremic M. Interaction of bacterial endotoxin and liquoid with blood platelets: aggregation and decrease in the electrokinetic charge. Thromb. Diath. Haemorrh. 1969; 22: 192
  • Weiss H. J. Platelet physiology and abnormalities of platelet function. N. Engl. J. Med. 1975; 293: 531, 580
  • Stuart M. J. Inherited defects of platelet function. Semin. Hematol. 1975; 12: 233
  • Marcus A. J. Platelet function. N. Engl. J. Med. 1969; 280: 1213, 1278, 1330
  • Harker L. A. Platelet production. N. Engl. J. Med. 1970; 282: 492
  • Deykin D. Emerging concepts of platelet function. N. Engl. J. Med. 1974; 290: 144
  • White J. G. Current concepts of platelet structural physiology and pathology. Hum. Pathol. 1974; 5: 11
  • Salzman E. W. Cyclic AMP and platelet function. N. Engl. J. Med. 1972; 286: 358
  • Karpatkin S. Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J. Clin. Invest. 1969; 49: 1083
  • McPherson J., Zucker M. Platelet retention in glass bead columns; adhesion to glass and subsequent platelet-platelet interactions. Blood 1976; 47: 55
  • Gralnick H., Collier B. S., Shulman N. R., Andersen J. C., Hilgartner M. Factor VIII. Ann. Intern. Med. 1977; 86: 598
  • Tschopp T. B., Weiss H. J., Baumgartner H. R. Decreased adhesion of platelets to suben-dothelium in von Willebrand's diseases. J. Lab. Clin. Med. 1974; 83: 296
  • Weiss H. J., Tschopp T. B., Baumgartner H. R. Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion: a comparison with von Willebrand's disease. N. Engl. J. Med. 1975; 293: 619
  • French J. E. Thrombosis in arteries: the role of the blood platelets. Pathol. Microbiol. 1967; 30: 653
  • Mustard J. F. Platelets in thromboembolic disease. Adv. Cardiol. 1970; 4: 131
  • Farbiszewski R., Lipinski B., Niewiarowski S., Poplawski A. Hypercoagulability and throm-bocytopenia after platelet factor IV infusion into rabbits. Experientia 1968; 24: 578
  • Okuno T., Crockatt D. Platelet factor IV activity and thromboembolic episodes. Am. J. Clin. Pathol. 1977; 67: 351
  • Stuart R. K., McDonald J. W., Ahuja S. P., Coles J. C. Platelet survival in patients with prosthetic heart valves. Am. J. Cardiol. 1974; 33: 840
  • Chao F. C., Tullis J. L., Conneely G. S., Lawler J. W. Aggregation of platelets and inert particles induced by thrombin. Thromb. Haemostas. 1976; 35: 717
  • Harker L. A., Slichter S. J. Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy. Thromb. Diath. Haemorrh. 1974; 31: 188
  • Harker L. A., Slichter S. J. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. N. Engl. J. Med. 1970; 283: 1302
  • Harker L. A., Slichter S. J. Platelet and fibrinogen consumption in man. N. Engl. J. Med. 1972; 287: 9999
  • Harker L. A., Slichter S. J. The bleeding time as a screening test for evaluation of platelet function. N. Engl. J. Med. 1972; 287: 155
  • Negus D., Pinto D. J., Brown N. Platelet adhesiveness in postoperative deep-vein thrombosis. Lancet 1969; 1: 220
  • O'Brien J. R., Tulevski V. G., Etherington M., Madgwick T., Alkjaersig N., Fletcher A. Platelet function studies before and after operation and the effect of postoperative thrombosis. J. Lab. Clin. Med. 1974; 83: 342
  • Steele P. P., Weily H. S., Genton E. Platelet survival and adhesiveness in recurrent venous thrombosis. N. Engl. J. Med. 1973; 288: 1148
  • Wu K. K., Barnes R. W., Hoak J. C. Platelet hyperaggregability in idiopathic recurrent deep-vein thrombosis. Circulation 1976; 53: 687
  • Genton E., Gent M., Hirsh J., Harker L. A. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease. N. Engl. J. Med. 1975; 293: 1174, 1236, 1296
  • Kakkar V. V., Nicolaides A. N., Field E. S., Flute P. T., Wessler S., Yin E. T. Low doses of heparin in prevention of deep-vein thrombosis. Lancet 1971; 2: 7726
  • Van Vroonhoven T. J. M. V., van Zijl J., Muller H. Low-dose subcutaneous heparin versus oral anticoagulants in the prevention of postoperative deep-venous thrombosis. A controlled clinical trial. Lancet 1974; 1: 375
  • LeQuesne L. P. Relation between deep-vein thrombosis and pulmonary embolism in surgical patients. N. Engl. J. Med. 1974; 291: 1292
  • Gallus A. S., Hirsh J. Prevention of venous thromboembolism. Semin. Thromb. Hemostas. 1976; 2: 232
  • Deykin D. Local and systemic factors in the pathogensis of thrombosis. Calif. Med. 1970; 112: 31
  • Fratantpni J. C., Ness P., Simon T. L. Thrombolytic therapy. Current status. N. Engl. J. Med. 1975; 293: 1073
  • Deykin D. The clinical challenge of disseminated intravascular coagulation. N. Engl. J. Med. 1970; 283: 636
  • Wells R. Syndromes of hyperviscosity. N. Engl. J. Med. 1970; 283: 183
  • Tullis J. L. Clot. Charles C Thomas, Springfield, Ill 1976
  • Kropatkin M. L., Izak G. Studies on the hypercoagulable state. The regulation of fibrinogen production in experimental hyper-and hypofibrinogenemia. Thromb. Diath. Haemorrh. 1968; 19: 547
  • Robboy S. J., Colman R. W., Minna J. D. Pathology of disseminated intravascular coagulation (DIC). Analysis of 26 cases. Hum. Pathol. 1972; 3: 327
  • Penick G. D., Roberts H. R., Dejanov I. I. Covert intravascular clotting. Fed. Proc. Am. Soc. Exp. Biol. 1965; 24: 835
  • Pochedly C., Miller S. P., Mehta A. 'Hypercoagulable state' in children with acute leukemia or disseminated solid tumors. Oncology 1973; 28: 517
  • Goldenfarb P. B. Reproducibility in coagulation assays. Am. J. Clin. Pathol. 1971; 55: 561
  • McPherson R. A. Thromboembolism in Hageman trait. Am. J. Clin. Pathol. 1977; 68: 420
  • Ratnoff O. D., Busse R. J., Sheon R. P. The demise of John Hageman, N. Engl. J. Med. 1968; 279: 760
  • Fletcher A. P., Alkjaersig N., O'Brien J., Tulevski V. G. Blood hypercoagulability and thrombosis. Trans. Assoc. Am. Physicians 1970; 83: 159
  • Marciniak E., Farley C. H., DeSimone P. A. Familial thrombosis due to antithrombin III deficiency. Blood 1974; 43: 219
  • Van Der Meer J., Stoepman-Van Dalen E. A., Jansen J. M. S. Antithrombin III deficiency in a Dutch family. J. Clin. Pathol. 1973; 26: 532
  • Minard B., Petersen C. A. Comparison of functional and immunologic antithrombin III values. Am. J. Clin. Pathol. 1976; 66: 459, (Abstr.)
  • Rickman F. D., Handin R., Howe J. P., Alpert J. S., Dexter L., Dalen J. E. Fibrin split products in acute pulmonary embolism. Ann. Intern. Med. 1973; 19: 664
  • Seaman A. J. The recognition of intravascular clotting. The Plasma protamine paracoagulation test. Arch. Intern. Med. 1970; 125: 1016
  • Gallus A. S., Hirsh J., Gent M. Relevance of preoperative and postoperative blood tests to postoperative leg-vein thrombosis. Lancet 1973; 2: 7833
  • Kideer W. R., Logan L. J., Rapaport S. I., Patch M. J. The plasma protamine paracoagulation test: clinical and laboratory evaluation. Am. J. Clin. Pathol. 1972; 58: 675
  • Francis P. B., Wilson J. E. Correlation of the serial-dilution protamine sulfate test with models of “hypercoagulability” and thrombosis in dogs. Am. J. Clin. Pathol. 1977; 67: 356
  • Lipinski B. Detection of hypercoagulable states with protamine sulphate tests. Acta Univ. Carol. Med. Monogr. 1972; 52: 185
  • Von Kaulla E., von Kaulla K. N. Detection of hypercoagulability states by a modified ethanol gelation test and its correlation with other coagulation procedures. Am. J. Clin. Pathol. 1974; 61: 810
  • Breen F. A., Tullis J. L. Ethanol gelation: a rapid screening test for intravascular coagulation. Ann. Intern. Med. 1968; 69: 1197
  • Smith S. B., Arkin C. Cryofibrinogenemia: incidences, clinical correlations and a review of the literature. Am. J. Clin. Pathol. 1972; 58: 524
  • Mosesson M. W., Colman R. W., Sherry S. Chronic intravascular coagulation syndrome. Report of a case with special studies of an associated plasma, cryoprecipitate (“Cryofibrinogen”). N. Engl. J. Med. 1968; 278: 815
  • McKee P. A., Kalbfleisch J. M., Bird R. M. Incidence and significance of cryofibrinogenemia. J. Lab. Clin. Med. 1963; 61: 203
  • Von Kaulla E., Droegemueller W., Aoki N., von Kaulla K. N. Effect of estrogens on post-partum hypercoagulability and antithrombin III activity. Am. J. Obstet. Gynecol. 1972; 113: 920
  • Zawilska A., Furmaniuk J. Usefulness of a modified thrombin generation test in the diagnosis of chronometric hypercoagulability. Acta Haematol. Pol. 1972; 3(2)155
  • Nossel H. L. Radioimmunoassay of fibrinopeptides in relation to intravascular coagulation and thrombosis, N. Engl. J. Med. 1976; 295: 428
  • Kockum C. Radioimmunoassay of fibrinopeptide A. Clinical application. Thromb. Res. 1976; 8: 225
  • Browse N. L. The 125I fibrinogen uptake test. Arch. Surg. (Chicago) 1972; 104: 160
  • Madden J. L., Hume M. Venous thromboembolism: prevention and treatment. Appleton-Century-Crofts, New York 1976
  • Harris W. H., Salzman E. W., Athanasoulis C., Waltman A., Baum S., DeSanctis R. W., Potsaid M. S., Sise H. Comparison of 125I fibrinogen count scanning with phylebography for detection of venous thrombi after elective hip surgery. N. Engl. J. Med. 1975; 292: 665
  • Mullick S. C., Wheeler H. B., Songster G. F. Diagnosis of deep-vein thrombosis by measurement of electrical impedance. Am. J. Surg. 1970; 119: 417
  • Wheeler H. B., Pearson D., O'Connell D., Mullick S. C. Impedance phlebography: technique, interpretation and results. Arch. Surg. (Chicago) 1972; 104: 164
  • Steer M. L., Spotnitz A. J., Cohen S. I., Paulin S., Salzman E. W. Limitations of impedance phlebograpy for diagnosis of venous thrombosis. Arch. Surg. (Chicago) 1973; 106: 44
  • Harris W. H., Sara S. M., Salzman E. W., DeSanctis R. W., Waltman A. C., Athanasoulis C. Impedance phlebography in the diagnosis of deep-vein thrombosis. Surgery 1973; 74: 385
  • Cranley J. J., Gay A. Y., Grass A. M., Simeone F. A. A plethysmographic technique for the diagnosis of deep-vein thrombosis of the lower extremities. Surg. Gynecol. Obstet. 1973; 136: 385
  • Johnston K. W., Kakkar V. V., Spindler J. J., Corrigan T. P., Fossard D. P. A simple method for detecting deep-vein thrombosis. An improved electrical impedance technic. Am. J. Surg. 1974; 127: 349
  • Wheeler H. B., O'Donnell J. A., Anderson F. A., Benedict K. Occlusive impedance phlebography: a diagnostic procedure for venous thrombosis and pulmonary embolism. Prog. Cardiovasc. Dis. 1974; 17: 199
  • Hull R., van Aken W. G., Hirsh J., Gallus A. S., Koicka G., Turpie A. G. C., Walker I., Gent M. Impedance plethysmography using the occlusive cuff technique in the diagnosis of venous thrombosis. Circulation 1976; 53: 696
  • Mavor G. E., Galloway J. M. D. The iliofemoral venous segment as a source of pulmonary emboli. Lancet 1967; 1: 871
  • Hull R., Hirsh J., Sackett D. L., Powers P., Turpie A. G. G., Walker I. Leg scanning and impedance plethysmography to detect venous thrombosis. N. Engl. J. Med. 1977; 296: 1497
  • Sigel B., Felix R., Popky G. L., Ipsen J. Diagnosis of lower limb venous thrombosis by Doppler ultrasound technique. Arch. Surg. (Chicago) 1972; 104: 174
  • Evans D. S. The early diagnosis of deep-vein thrombosis by ultra sound. Br. J. Surg. 1970; 57: 726
  • Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb. Diath. Haemorrh. 1965; 13: 516
  • Shapiro S. S., Prager D., Martinez J. Inherited antithrombin III deficiency associated with multiple thromboembolic phenomena. Blood 1973; 42: 1001, (Abstr.)
  • Sas G., Blaskó G., Banhegyi D., Jákó J., Palos L. A. Abnormal antithrombin III (Antithrombin III “Budapest”) as a cause of a familial thrombophilia. Thromb. Diath. Haemorrh. 1974; 32: 105
  • Mengel C. E., Frei E., Nachman R. Hematology: principles and practice. Year Book Medical Publishing, Chicago 1972
  • Von Kaulla E., von Kaulla K. N. Antithrombin III and diseases. Am. J. Clin. Pathol. 1967; 48: 69
  • Koszewski B. J., Vahabzadeh H. Hypercoagulability syndrome due to heparin co-factor deficiency. Thromb. Diath. Haemorrh. 1964; 11: 485
  • Hennekens C. H., MacMahon B. Oral contraceptives and myocardial infarction. N. Engl. J. Med. 1977; 296: 1166
  • Boston Collaborative Drug Surveillance Programme, Oral contraceptives and venous thromboembolic diseases, surgically confirmed gallbladder disease, and breast tumors. Lancet 1973; 1: 7817
  • Frederiksen H., Ravenholt R. T. Thromboembolism, oral contraceptives, and cigarettes. Public Health Rep. 1970; 85: 197
  • Collaborative Group for the Study of Stroke in Young Women, Oral contraception and increased risk of cerebral ischemia or thrombosis. N. Engl. J. Med. 1973; 288: 871
  • Vessey M. P., Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. Br. Med. J. 1968; 2: 199
  • Sartwell P. E., Masi A. T., Arthes F. G., Greene G. R., Smith H. E. Thromboembolism and oral contraceptives: an epidemiologic case-control study. Am. J. Epidemiol. 1969; 90: 365
  • Beral V. Cardiovascular disease mortality trends and oral contraceptives use in young women. Lancet 1976; 2: 1047
  • Mann J. I., Inman W. H. W. Oral contraceptives and death from myocardial infarction. Br. Med. J. 1975; 2: 245
  • Mann J. I., Vessey J. P., Thorogood M., Doll R. Myocardial infarction in young women with special reference to oral contraceptive practice. Br. Med. J. 1975; 2: 241
  • Bader M. Oral contraceptives and myocardial infarction (Letter). N. Engl. J. Med. 1977; 297: 449
  • Zimmerman T. S., Adelson L., Ratnoff O. S. Plumonary embolism and unexpected death in supposedly normal persons, A second look. N. Engl. J. Med. 1970; 283: 1504
  • Von Kaulla E., von Kaulla N., Droegemueller W. Clinical hypercoagulability and oral contraceptives. Laboratory detection. Rocky Mount. Med. J. 1972; 69(6)33
  • Renaud S., Gautheron P. Role of platelet factor III in the hypercoagulability induced by pregnancy and oral contraceptives. Thromb. Diath. Haemorrh. 1973; 30: 299
  • Lipinska I., Lipinski B., Gurewich V., Hoffman K. D. Fibrinogen heterogeneity in cancer, in occlusive vascular disease, and after surgical procedures. Am. J. Clin. Pathol. 1976; 66: 958
  • Brodsky I. Leukemia and the hypercoagulable state. Pathogenic and therapeutic implication. J. Med. (Basel) 1974; 5: 38
  • Sun N. C. J., Bowie E. J. W., Kazmier F. J., Elveback L. R., Owen C. A. Blood coagulation studies in patients with cancer. Mayo Clin. Proc 1974; 49: 636
  • Case 44–1976, Case records of the Massachusetts General Hospital: weekly clinicopathological exercises. N. Engl. J. Med. 1976; 295: 1003
  • Case 48–1974, Case records of the Massachusetts General Hospital: weekly clinicopathological exercises. N. Engl. J. Med. 1974; 291: 1246
  • Reagan T. J., Okazaki H. The thrombotic syndrome associated with carcinoma. Arch. Neurol. 1974; 31: 390
  • Sproul E. E. Carcinoma and venous thrombosis: the frequency of association of carcinoma in the body or tail of the pancreas with multiple venous thrombosis. Am. J. Cancer 1938; 34: 566
  • Hagedorn A. B., Bowie E. J. W., Elveback L. R., Owen C. A. Coagulation abnormalities in patients with inoperable lung cancer. Mayo Clin. Proc 1974; 49: 647
  • Sanchez-Avalos J., Soong B. C. F., Miller S. R. Coagulation disorders in cancer. II. Multiple myeloma. Cancer (Philadelphia) 1969; 23: 1388
  • Stuart R. K. Hypercoagulability—1974, Editorial. Can. Med. Assoc. J. 1974; 110: 881
  • Kakkar V. V. The diagnosis of deep-vein thrombosis using the 125I fibrinogen test. Arch. Surg. (Chicago) 1972; 104: 152
  • MacKenzie I. Z., Sayers L. Coagulation changes during second-trimester abortion induced by intra-amniotic prostaglandin E2 and hypertonic solutions. Lancet 1975; 2: 1066
  • Bonnar J., McNicol G. P., Douglas A. S. Coagulation and fibrinolytic mechanisms during and after normal childbirth. Br. Med. J. 1970; 2: 200
  • Astedt B. Significance of placenta in depression of fibrinolytic activity during pregnancy. J. Obstet. Gynaecol. Br. Commonw. 1972; 79: 205
  • Bonnar J., Prentice C. R. M., McNicol G. P., Douglas A. S. Hemostatic mechanism in the uterine circulation during placental separation. Br. Med J. 1970; 1: 564
  • Husni E. A., Pena L. I., Lennert A. E. Thrombophlebitis in pregnancy. Am. J. Obstet. Gynecol. 1967; 97: 901
  • Reid D. E., Frigoletto F. D., Tullis J. L., Hinman J. Hypercoagulable states in pregnancy. Am. J. Obstet. Gynecol. 1971; 111: 493
  • Frigoletto F. D., Tullis J. L., Reid D. E., Hinman J. Hypercoagulability in the dysmature syndrome. Am. J. Obstet. Gynecol. 1971; 111: 867
  • Born G. V. R., Cross M. J. The aggregation of blood platelets. J. Physiol. (London) 1963; 168: 178
  • Carvalho A. C. A., Colman R. W., Lees R. S. Platelet function in hyperlipoproteinemia. N. Engl. J. Med. 1974; 290: 434
  • O'Malley B. C., Ward J. D., Timperley W. R., Porter N. R., Preston F. E. Platelet abnormalities in diabetic peripheral neuropathy. Lancet 1975; 2: 1274
  • Colwell J. A., Halushka P. V., Sarji K., Levine J., Sagel J., Nair R. M. G. Altered platelet function in diabetes mellitus. Diabetes 1976; 25(2)826
  • Sagel J., Colwell J. A., Crook L., Laimins M. Increased platelet aggregation in early diabetes mellitus. Ann. Intern. Med. 1975; 82: 733
  • Olson J. D., Brockway W. J., Fass D. N., Magnuson M. A., Bowie E. J. W. Evaluation of restocetin-Willebrand factor assay and restocetin-induced platelet aggregation. Am. J. Clin. Pathol. 1975; 63: 210
  • Weiss H. J., Hoyer L. W., Rickles F. R., Varma A., Rogers J. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. J. Clin. Invest. 1973; 52: 2708
  • Bowie E. J. W., Owen C. A. Some factors influencing platelet retention in glass bead columns including the influence of plastics. Am. J. Clin. Pathol. 1971; 56: 479
  • Bowie E. J. W., Owen C. A. The value of measuring platelet “adhesiveness” in the diagnosis of bleeding diseases. Am. J. Clin. Pathol. 1973; 60: 302
  • Wu K. K., Hoak J. C. Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications. Thromb. Haemostas. 1976; 35: 702
  • Friedlander I., Cook I. J. Y., Hawkey C., Symons C. A laboratory study of spontaneous platelet aggregation. J. Clin. Pathol. 1971; 24: 323
  • Kardinal C. G., Wegener L. T., Anderson L. K. Spontaneous platelet aggregation. Occurrence in an asymptomatic individual. Am. J. Clin. Pathol. 1975; 63: 599
  • Wu K. K., Hoak J. C. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; 2: 924
  • Schwartz A. D. A method for demonstrating shortened platelet survival utilizing recovery from aspirin effect. J. Pediatr. 1974; 84: 350
  • Stuart M. J., Murphy S., Oski F. A. A simple nonradioisotope technic for the determination of platelet life-span. N. Engl. J. Med. 1975; 292: 1310
  • Karpatkin S., Garg S. K. The megathrombocyte as an index of platelet production. Br. J. Haematol. 1974; 26: 307
  • Garg S. K., Lackner H., Karpatkin S. The increased percentage of megathrombocytes in various clinical disorders. Ann. Intern. Med. 1972; 77: 361
  • Garg S. K., Amorosi E. L., Karpatkin S. Use of the megathrombocyte as an index of megak-aryocyte number. N. Engl. J. Med. 1971; 284: 11
  • Dana B., Carvalho A. C., Ellman L. Plasma heparin neutralizing activity. Its use in the evaluation of thrombocytopenia and thrombocytosis. Am. J. Clin. Pathol. 1976; 65: 964
  • Feinstein A. R. More blood for the anticoagulant battle. N. Engl. J. Med. 1975; 292: 1400
  • Fuster V., Bowie J. W., Kazmier F. J., Owen C. A. Platelet consumption in chronically induced plasma platelet factor IV—like activity reflecting rate of intravascular coagulation in dogs. Thromb. Res. 1974; 4: 247
  • Ross R., Glomset J. A. The pathogenesis of atherosclerosis. N. Engl. J. Med. 1976; 295: 369, 420
  • Mustard J. F., Pakman M. A. The role of blood and platelets in atherosclerosis and the complications of atherosclerosis. Thromb. Diath. Haemorrh. 1975; 33: 444
  • Antoniades H. N., Stathakos D., Scher C. D. Isolation of a cationic polypeptide from human serum and stimulates proliferation of 3T3 cells. Proc. Natl. Acad. Sci. U.S.A. 1975; 72: 2635
  • Burns E. R., Friedman R. J., Tiell M. L., Spaet T. H., Stemerman M. B. Platelet activity in pathogenesis of atherosclerosis (Letter). N. Engl. J. Med. 1976; 295: 1199
  • Friedman M., Van den Bovenkamp G. J. The pathogenesis of a coronary thrombus. Am. J. Pathol. 1966; 48: 19
  • Haerem J. Platelet aggregates and nural microthrombi in the early stages of acute, fatal coronary disease. Thromb. Res. 1974; 5: 243
  • Jørgensen L., Rowsell H. C., Hovig T., Glynn M. F., Mustard J. F. Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine. Lab. Invest. 1967; 17: 616
  • Willis A. L. Isolation of a chemical trigger for thrombosis. Prostaglandins 1974; 5: 1
  • Maekawa T., Kobayaski N., Arai H., Takeuchi T. Role of blood platelet in the formation of thrombus. Thromb. Res. 1976; 8(2)227
  • Dreyfuss F., Zahavi J. Adenosine diphosphate induced platelet aggregation in myocardial infarction and ischemic heart disease. Atherosclerosis 1973; 17: 107
  • Hampton J. R., Gorlin R. Platelet studies in patients with coronary artery disease and in their relatives. Br. Heart J. 1972; 34: 465
  • Yamazaki H., Takahashi T., Sano T. Hyperaggregability of platelets in thromboembolic disorders. Thromb. Diath. Haemorrh. 1975; 34: 94
  • Davis J. W. Defective platelet disaggregation associated with occlusive arterial diseases. Angiology 1973; 24: 391
  • Zahavi J. Hyperaggregability of platelets in thromboembolic disorders (Letter). Thromb. Haemostas. 1976; 36: 479
  • Yamazaki H., Sano T., Asano T., Hidaka H. Hyperaggregability of platelets in thromboembolic disorders. Thromb. Res. 1976; 8(2)217
  • Salky N., Dugdale M. Platelet abnormalities in ischemic heart disease. Am. J. Cardiol. 1973; 32: 612
  • Danta G. Second phase platelet aggregation induced by adenosine diphosphate in patients with cerebral vascular disease and in control subjects. Thromb. Diath. Haemorrh. 1970; 23: 159
  • Walker I. D., Davidson J. F., Hulton I., Lawrie T. D. Disordered fibrinolytic potential in coronary heart disease. Thromb. Res. 1977; 10: 509
  • Fletcher A., Alkjaersig N., Owens O., Wolff G., Smith J. R. Blood hypercoagulability, thrombosis, and acute myocardial infarction. J. Lab. Clin. Med. 1971; 78: 798
  • Bridges J. M., Dably A. M., Millar J. H. D., Weaver J. A. An effect of D-glucose on platelet stickiness. Lancet 1965; 1: 75
  • Mayne E. E., Bridges J. M., Weaver J. A. Platelet adhesiveness, plasma fibrinogen and factor VIII levels in diabetes mellitus. Diabetologia 1970; 6: 436
  • Shaw S., Pegrun G. D., Wolff S., Ashton W. L. Platelet adhesiveness in diabetes mellitus. J. Clin. Pathol. 1967; 20: 845
  • Szanto S., Yudkin J. The effect of dietary sucrose on blood lipids, serum insulin, platelet adhesiveness and body weight in human volunteers. Postgrad. Med. J. 1969; 45: 602
  • Hellem A. J. Adenosinediphosphate induced platelet adhesiveness in diabetes mellitus with complications. Acta Med. Scand. 1971; 190: 291
  • Heath H., Bridgen W. D., Canever J. V., Pollock P. R., Hunter J. K., Bloom A. Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia 1971; 7: 308
  • Murchison L. E., Fyfe T. Effects of cigarette smoking on serum-lipids, blood-glucose, and platelet adhesiveness. Lancet 1966; 2: 182
  • Colwell J. A., Sagel J., Crook L., Chambers A., Laimins M. Correlation of platelet aggregation, plasma factor activity, and megathrombocytes in diabetic subjects with and without vascular disease. Metabolism 1977; 26: 279
  • Davis J. W., Yue K. T. N., Phillips F. E., McField J. R. Adenosine dephosphate-induced platelet aggregation of hospitalized men. Scand. J. Haematol. 1974; 13: 17
  • Halushka P., Weiser C., Chambers A. Advances in prostaglandin and thromboxane research. Proc. Int. Conf. Prostaglandins, B. Sammuelson, R. Paoletti. Raven Press, New York 1975
  • Colwell J. A., Chambers A., Laimins M. Inhibition of labile aggregation-stimulating substance (LASS) and platelet aggregation in diabetes melletus. Diabetes 1975; 24: 684
  • Greenberg J., Packham M. A., Cazenave J. P., Reimers H. J., Mustard F. Effects on platelet function of removal of platelet sialic acid by neuraminidase. Lab. Invest. 1975; 32: 476
  • Sulfonylureas: effects in vivo and in vitro, NIH Conference. Ann. Intern. Med. 1971; 75: 607
  • Kwaan H. C., Colwell J. A., Cruz S., Suwanwela N., Dobbie J. G. Increased platelet aggregation in diabetes mellitus. J. Lab. Clin. Med. 1972; 80: 236
  • Kwaan H. C., Colwell J. A., Suwanwela N. Disseminated intravascular coagulation in diabetes mellitus, with reference to the role of increased platelet aggregation. Diabetes 1972; 21: 108
  • Bensoussan D., Levy-Toledano S., Passa P., Caen J., Canivet J. Platelet hyperaggregation and increased plasma level of von Willebrand factor in diabetics with retinopathy. Diabetologia 1975; 11: 307
  • Pandolfi M., Almér L. O., Holmberg L. Increased von Willebrand-antihaemophilic factor A in diabetic retinopathy. Acta Ophthalmol. 1974; 52: 823
  • Chmielewski J., Farbiszewski R. Platelet factor IV (PF4) release during human platelet aggregation in diabetic patients. Thromb. Diath. Haemorrh. 1970; 24: 203
  • Shattil S. J., Bennett J. S., Colman R. W., Cooper R. A. Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteine-mia. J. Lab. Clin. Med. 1977; 89: 341
  • Shattil S. J., Anaya-Galindo R., Bennet J. S., Colman R. W., Cooper R. A. Platelet hyper-sensitivity induced by cholesterol incorporation. J. Clin. Invest. 1975; 55: 636
  • Farbiszewski R., Skrzydlewski Z., Worowski K. The effect of lipoprotein fractions on adhesiveness and aggregation of blood platelets. Thromb. Diath. Haemorrh. 1969; 21: 89
  • Nordoy A. Lipids as triggering factors in thrombosis. Thromb. Haemostas. 1976; 35: 32
  • Fleischman A., Bierenbaum M. L., Justice D., Stier A., Sullivan A., Fleischman M. Titrating dietary linoleate to in vivo platelet function in man. Am. J. Clin. Nutr. 1975; 28: 601
  • Hornstra G., Chait A., Karvonen M. J., Lewis B., Tutpeinen O., Vergroesen A. J. Influence of dietary fat on platelet function in man. Lancet 1973; 1: 1155
  • Privett O. S., Phillips F., Fukazawa T., Kaltenbach C. C., Sprecher H. W. Studies on the relationship of the synthesis of prostaglandins to the biological activity of essential fatty acids. Biochim. Biophys. Acta 1972; 280: 348
  • Gjesdal K., Nordoy A., Wang H., Berntsen H., Mjos O. D. Effects of fasting on plasma and platelet-free fatty acids and platelet function in healthy males. Thromb. Haemostas. 1976; 36(2)325
  • Mustard J. F., Murphy E. A. Effect of smoking on blood coagulation and platelet survival in man. Br. Med. J. 1963; 1: 846
  • Levine P. H. An acute effect of cigarette smoking and arterial thrombosis. Circulation 1973; 48: 619
  • Doyle J. T., Dawber T. R., Kannel W. B., Kinch A. S., Kahn H. A. Cigarette smoking and coronary heart disease: combined Albany-Framingham study. Circulation 1961; 24: 921, (Abstr.)
  • Hawkins R. L. Smoking, platelets and thrombosis. Nature (London) 1972; 236: 450
  • Horns D. J., Gerrard J. M., Rao G. H., Krivit W., White J. G. Smoking and platelet labile aggregation stimulating substance (LASS) synthesizing activity. Thromb. Res. 1976; 9: 661
  • Handley A. J., Teather D. Influence of smoking on deep-vein thrombosis after myocardial infarction. Br. Med. J. 1974; 3: 230
  • Marks P., Emerson P. A. Increased incidence of deep-vein thrombosis after myocardial infarction in non-smokers. Br. Med. J. 1974; 3: 232
  • Eurenius K., Rothenberg J., Johnson R. Platelet aggregation after thermal injury. J. Lab. Clin. Med. 1974; 83: 355
  • Mims J. A., Sarji K. E., Kleinfelder J. S., Eurenius K. Heparin-induced platelet aggregation in burn patients. Thromb. Res. 1977; 10: 291
  • Eika C. On the mechanism of platelet aggregation induced by heparin, protamine and polybrene. Scand. J. Haematol. 1972; 9: 248
  • Warlow C. P., Ogston D. Effect of exercise on platelet count, adhesion, and aggregation. Acta Haematol. 1974; 52: 47
  • Rodriquez-Erdmann F. Studies on the pathogenesis of the generalized Shwartzman reaction. III. Trigger mechanism for the activation of the prothrombin molecule. Thromb. Diath. Haemorrh. 1964; 12: 471
  • Emmons P. R., Mitchell J. R. A. Postoperative changes in platelet clumping activity. Lancet 1965; 1: 71
  • Ham J. M., Slack W. W. Platelet adhesiveness after operation. Br. J. Surg. 1967; 54: 385
  • Steinberg D., Carvalho A. C., Chesney C. M., Colman R. W. Platelet hypersensitivity and intravascular coagulation in paroxysmal nocturnal hemoglobinuria. Am. J. Med. 1975; 59: 845
  • Williams W. J., Beutler E., Erslev A. J., Rundles R. W. Hematology2nd ed. McGraw-Hill, New York 1977; 1364
  • Miale J. B. Laboratory Medicine: Hematology5th ed. C. V. Mosby, St Louis 1977; 932
  • Wu K. K. Platelet Hyperaggregability and thrombosis in patients with thrombocythemia. Ann. Intern. Med. 1978; 88: 7
  • Preston F. E., Emmanuel I. G., Winfield D. A., Malia R. G. Essential thrombocythemia and peripheral gangrene. Br. Med. J. 1974; 3: 548
  • Zucker S., Mielke C. H. Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications. J. Lab. Clin. Med. 1972; 80: 385
  • Ginsberg A. D. Platelet function in patients with high platelet counts. Ann. Intern. Med. 1975; 82: 506
  • Cooper B., Schafer A., Handin R. I. Diminished platelet sensitivity to prostaglandin D2 in the pathogenesis of thrombosis associated with myeloproliferative disorders. Blood 1977; 50: 263

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.